New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
July 18, 2024 07:20 ET
|
F. Hoffmann-La Roche Ltd
Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR)Safety data were...
Share Buyback Transaction Details July 11 – July 17, 2024
July 18, 2024 04:00 ET
|
Wolters Kluwer N.V.
PRESS RELEASE Share Buyback Transaction Details July 11 – July 17, 2024 Alphen aan den Rijn – July 18, 2024 - Wolters Kluwer (Euronext: WKL), a global leader...
LIFT To Acquire Shorty West Lithium Claim
July 18, 2024 03:05 ET
|
Li-FT Power Ltd.
VANCOUVER, British Columbia, July 18, 2024 (GLOBE NEWSWIRE) -- Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce that it has entered into...
La filiale de DeFi Technologies, Valour Inc., annonce le lancement du premier produit négocié en bourse au monde pour le token NEAR Protocol
July 17, 2024 17:44 ET
|
DeFi Technologies Inc.
Lancement du premier ETP NEAR Protocol au monde : Valour Inc, filiale de DeFi Technologies, lance le premier produit négocié en bourse (ETP) au monde pour le token NEAR Protocol sur le marché boursier...
DeFi Technologies' Tochtergesellschaft Valour Inc. kündigt die Einführung des weltweit ersten Exchange Traded Product für das NEAR Protocol-Token an
July 17, 2024 17:44 ET
|
DeFi Technologies Inc.
Weltweit erstes NEAR Protocol-ETP auf dem Markt: Valour Inc., eine Tochtergesellschaft von DeFi Technologies, hat das weltweit erste Exchange Traded Product (ETP) für das NEAR Protocol-Token an der...
Weekly share repurchase program transaction details
July 17, 2024 12:24 ET
|
SBM Offshore Amsterdam B.V.
July 17, 2024 SBM Offshore reports the transaction details related to its EUR65 million (c. US$70 million) share repurchase program for the period July 11, 2024 through July 17, 2024. The...
Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study
July 17, 2024 11:45 ET
|
F. Hoffmann-La Roche Ltd
More than 90% of patients had absence of DME after four years in a pre-specified exploratory endpointPeople treated with Vabysmo sustained vision gains and anatomical improvements, with almost 80%...
Dror Ortho-Design, Inc. Launches New ZSMILE Product Brand
July 17, 2024 09:00 ET
|
Dror Ortho-Design, Inc.
JERUSALEM, July 17, 2024 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to...
REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System
July 17, 2024 09:00 ET
|
RemSleep Holdings, Inc.
REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System
AITX’s Steve Reinharz to Discuss Recent Developments During Upcoming ‘Ask Me Anything’
July 17, 2024 08:40 ET
|
Artificial Intelligence Technology Solutions, Inc.
Topics Expected to be Discussed are Q1 Results, Fiscal Year Outlook, and New Solution Development Progress Detroit, Michigan, July 17, 2024 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology...